Glashuetten
Germany
34
2016-12-08
The entities that hold a legal rights for patent applications filed by inventor UHLMANN Eugen:
Eugen UHLMANN from Glashuetten, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
INHIBITORY OLIGONUCLEOTIDES AND THEIR USE IN THERAPY
#2 | 2016-12-01CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity
#3 | 2015-12-03INHIBITORY OLIGONUCLEOTIDES AND THEIR USE IN THERAPY
#4 | 2014-06-12CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity
#5 | 2013-06-27Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties
#6 | 2012-08-30COMBINATION MOTIF IMMUNE STIMULATORY OLIGONUCLEOTIDES WITH IMPROVED ACTIVITY
#7 | 2011-08-18SEMI-SOFT C-CLASS IMMUNOSTIMULATORY OLIGONUCLEOTIDES
#8 | 2011-06-075′ CpG nucleic acids and methods of use
#9 | 2011-04-28Immune stimulatory oligonucleotide analogs containing modified sugar moieties
#10 | 2010-11-11Class A Oligonucleotides with Immunostimulatory Potency
#11 | 2010-10-14Phosphate-modified oligonucleotide analogs with enhanced immunostimulatory activity
#12 | 2010-07-29Compositions of TLR ligands and antivirals
#13 | 2010-07-22NUCLEIC ACID-LIPOPHILIC CONJUGATES
#14 | 2010-07-01CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity
#15 | 2010-06-10Oligoribonucleotides and uses thereof
#16 | 2010-01-28Polyamide nucleic acid derivatives and agents, and processes for preparing them
#17 | 2009-12-10Modulation of Immunostimulatory Properties of Short Interfering Ribonucleic Acid (Sirna) by Nucleotide Modification
#18 | 2009-04-02Combination motif immune stimulatory oligonucleotides with improved activity
#19 | 2008-05-15Abasic Oligonucleotide as Carrier Platform for Antigen and Immunostimulatory Agonist and Antagonist
#20 | 2008-03-20Conjugates and processes for their preparation and their use for transporting molecules across biological membranes
#21 | 2008-03-20Polyamide nucleic acid derivatives and agents, and processes for preparing them
#22 | 2008-02-21Compositions and methods for oligonucleotide formulations
#23 | 2007-09-27Immunostimulatory nucleic acids
#24 | 2007-07-10Polyamide nucleic acid derivatives, and agents, and processes for preparing them
#25 | 2007-06-12G cap-stabilized oligonucleotides
#26 | 2006-10-26Modified oligoribonucleotide analogs with enhanced immunostimulatory activity
#27 | 2006-06-29Semi-soft C-class immunostimulatory oligonucleotides
#28 | 2005-10-27C-class oligonucleotide analogs with enhanced immunostimulatory potency
#29 | 2005-10-27Sequence requirements for inhibitory oligonucleotides
#30 | 2005-06-16Nucleic acid-lipophilic conjugates
#31 | 2005-03-17Immunostimulatory nucleic acids
#32 | 2005-02-03Polyamide-oligonucleotide derivatives, their preparation and use
#33 | 2005-01-13Polyamide nucleic acid derivatives, and agents, and processes for preparing them
#34 | 2005-01-13Oligonucleotides which inhibit expression of the OB-RGRP protein
311557 ⎘